Infigratinib achieved statistically significant improvement in growth rate and body composition in a Phase 3 clinical trial that tested the BridgeBio Pharma drug in achondroplasia, the most common form of dwarfism. Regulatory submissions are planned for later this year. The post BridgeBio Stands Tall as Phase 3 Data Put Dwarfism Drug on Track for FDA…
Caris Life Sciences applies AI and machine learning to patient samples to detect cancer and as a companion diagnostic guiding the use of targeted cancer therapies. As a commercial-stage company, Caris’s upsized public markets debut is an outlier amid the continuing IPO freeze for clinical-stage biotechs developing new drugs. The post Precision Medicine Firm Caris…
Instead of taking a blind-trust approach to automation, consider a humans-in-the-loop strategy. The post The Bot Will See You Now: Why Clinicians Need AI Accountability appeared first on MedCity News.
The combination of Bristol Myers Squibb cancer drugs Opdivo and Yervoy landed FDA approvals for the first-line treatment of colorectal cancer and hepatocellular carcinoma. Several other products also expanded their approved uses in our recap of recent regulatory news. The post BMS Immunotherapy Combo Gets Two FDA Nods for GI Cancers in Span of a…
This collection of charts explores the variation in health spending across the population through an analysis of 2023 Medical Expenditure Panel Survey (MEPS) data.
From the FTC’s press release out today: Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’…
Through the years, I’ve seen 12 different GI specialists, countless gynecologists, and many other specialists. I’ve had at least 10 surgeries and procedures. Here are three ways to prevent your patients from going through the same thing. The post Endometriosis: The Complex, Whole-body Disease We Need to be Talking About appeared first on MedCity News.
[Sponsored] A report by Paubox maintains that many compliance failures are caused by false assumptions rather than negligence. The post 5 Email Security Misconceptions That Put Healthcare Organizations at Risk appeared first on MedCity News.
These are the findings from the American Medical Association’s 2024 Physician Practice Benchmark Survey. Physicians included in the survey include those who practice in the U.S., actively see patients, and have completed residency. Here is what the survey finds: Increasingly, physicians are less likely to work in small practices that they or other physicians own….
The FDA said consolidating safety reporting into a single platform, the Adverse Event Monitoring System (AEMS), will increase transparency and reduce costs. But like the legacy systems it replaces, AEMS reports are unverified so causation and frequency of events cannot be determined. The post FDA Transparency Push Expands to Monitoring Safety of Vaccines and Other…